The drugs have been hailed a monumental breakthrough in the war on obesity - but some users have reportedly suffered severe ...
The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.
The specialty pharmacy business may be the most attractive part of Walgreens as rumors swirl the company will be taken over ...
Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...
When the FDA declared an Ozempic and Wegovy shortage, business boomed for pharmacies making cheaper, off-brand versions of ...
4d
The WEGOVY market has experienced significant growth, driven by rising obesity rates and increasing demand for effective weight-loss treatments. Novo Nordisk's blockbuster drug has seen strong ...
The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...
The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...
The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.
People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...
Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback